Multiple sclerosis: Re-expression of a developmental gene in chronic lesions correlates with remyelination

Annals of Neurology

Volumn 41, Issue 6, 1997, Pages 797-805

  Capello, Elisabetta ^a   Voskuhl, Rhonda R ^b   McFarland, Henry F ^c   Raine, Cedric S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MYELIN BASIC PROTEIN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MULTIPLE SCLEROSIS; NERVE REGENERATION; ONTOGENY; PRIORITY JOURNAL; RELAPSE; REMYELINIZATION; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; EXONS; FEMALE; FETUS; GENES; GENES, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN SHEATH; NERVOUS SYSTEM DISEASES;

EID: 0031000474     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410616     Document Type: Article

References (34)

1. Raine CS. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 1994;36: 561-572
2. William KC, Ulvestad E, Hickey WF. Immunology of multiple sclerosis. Clin Neurosci 1994;2:229-245
3. McFarlin DE, McFarland HF. Multiple sclerosis (parts I and II). N Engl J Med 1982;307:1183-1188; 1246-1251
4. Cannella B, Raine CS. The adhesion molecule/cytokine profile of multiple sclerosis lesions. Ann Neurol 1995;37:424-435
5. Zeller NK, Hunkeler MJ, Campagnoni AT, et al. Characterization of mouse myelin basic protein mRNAs with a myelin basic protein cDNA clone. Proc Natl Acad Sci USA 1984;81:18-22
6. de Ferra F, Engh H, Hudson L, et al. Alternative splicing accounts for the four forms of myelin basic protein. Cell 1985; 43:721-727
7. Kamholz J, Toffeneti J, Lazzarini RA. Organization and expression of human myelin basic protein gene. J Neurosci Res 1988; 21:62-70
8. Roth HJ, Kronquist KE, Kerlero de Rosbo N, et al. Evidence for the expression of four myelin basic protein variants in developing human spinal cord through cDNA cloning. J Neurosci Res 1987;17:321-328
9. Kristensson K, Holmes KV, Duchela CS, et al. Increased levels of myelin basic protein manuscripts in virus-induced demyelination. Nature 1986;322:544-547
10. Jordan CA, Friedrich VL, DeFerra F, et al. Differential expression in myelin basic protein transcripts during central nervous system (CNS) remyelination. Cell Mol Neurobiol 1990;10: 3-18
11. Voskuhl RR, McFarlin DE, Rhame L, et al. A novel candidate autoantigen in a multiplex family with multiple sclerosis: prevalence of T-lymphocytes specific for an MBP epitope unique to myelination. J Neuroimmunol 1993;46:137-144
12. Fritz RB, Zhao ML. Encephalitogenicity of myelin basic protein exon-2 peptide in mice. J Neuroimmunol 1994;51:1-6
13. Segal BM, Raine CS, McFarlin DE, et al. Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination. J Neuroimmunol 1994;51:7-19
14. Raine CS, Wu E, Ivanyi J, et al. Multiple sclerosis: a protective or a pathogenic role for heat-shock protein 60 in the central nervous system? Lab Invest 1996;75:109-123
15. Raine CS. Demyelinating diseases. In: Davis RL, Robertson DM, eds. Textbook of neuropathology. 2nd ed. Baltimore: Williams & Wilkins, 1990:535-620
16. Jordan CA, Friedrich VL, Dubois-Dalcq M. In situ hybridization of myelin gene transcripts in developing mouse spinal cord. J Neurosci 1989;9:248-257
17. Weidenheim KM, Bodhireddy SR, Rashbaum WK, et al. Temporal and spatial expression of major myelin proteins in the human fetal spinal cord during the second trimester. J Neuropathol Exp Neurol 1996;55:734-745
18. Prineas JW, Connell F. Remyelination in multiple sclerosis. Ann Neurol 1979;5:22-31
19. Raine CS, Scheinberg LC, Waltz JM. Multiple sclerosis: oligodendrocyte survival and proliferation in an active, established lesion. Lab Invest 1981;45:534-546
20. Wu E, Raine CS. Multiple sclerosis: interactions between oligodendrocytes and hypertrophie astrocytes and their occurrence in other, non-demyelinating conditions. Lab Invest 1992;67: 88-99
21. Kamholz JF, de Ferra F, Puckett C, et al. Identification of three forms of human myelin basic protein by cDNA cloning. Proc Nad Acad Sci USA 1986;83:4962-4966
22. Kerlero de Rosbo N, Tang S, Bernard CCA. Comparative study of myelin basic protein isoforms in developing vertebrate central nervous system: absence of 21 · 5 and 20 · 2 kilodalton myelin basic proteins in chickens may point to their importance in mammalian myelinogenesis. Dev Neurosci 1991;13:34-40
23. Nagasato K, Farris RW, Dubois-Dalcq M, et al. Exon 2-containing myelin basic protein transcripts are expressed in lesions of relapsing experimental allergic encephalomyelitis. J Neuroimmunol 1997;72:21-25
24. Nye SH, Pelfry CM, Burkwit JJ, et al. Purification of immunologically active recombinant 21 · 5 kDa isoform of human myelin basic protein. Mol Immunol 1995;32:1131-1141
25. Voskuhl RR, Robinson ED, Segal BM, et al. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis. J Immunol 1994; 153:4834-4844
26. Zhao ML, Fritz RB. The immune response to a subdominant epitope in myelin basic protein exon-2 results in immunity to intra- and intermolecular dominant epitopes. J Neuroimmunol 1995;61:179-184
27. Voskuhl RR, Farris RW, Nagasato K, et al. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein. J Neuroimmunol 1996;70:103-111
28. McRae BL, Vanderlugt CL, DalCanto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-85
29. Fallis RJ, Raine CS, McFarlin DE. Chronic relapsing experimental allergic encephalomyelitis in SJL mice following the adoptive transfer of an epitope-specific T-cell line. J Neuroimmunol 1989;22:93-106
30. Cross AH, Touhy VK, Raine CS. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol 1993;146:261-269
31. Wucherpfennig KW, Weiner HL, Hafler DA. T-cell recognition of myelin basic protein. Immunol Today 1991;12:277-282
32. Martin R, Jaraquemada D, Flerlage M, et al. Fine specificity and HLA restriction of myelin basic protein specific cytotoxic T cell from multiple sclerosis patients and healthy individuals. J Immunol 1990;145:540-548
33. Rus HG, Niculescu F, Shin ML. Sublytic complement attack induces cell cycle in oligodendrocytes: S phase induction is dependent on c-jun activation. J Immunol 1996;156:4892-4900
34. Kamholtz J, Wrabetz R. Molecular genetics of myelin base protein. In: Martenson RE, ed. Myelin: biology and chemistry. Boca Raton, FL: CRC Press, 1992:367-385.